{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T22:20:54Z","timestamp":1778192454223,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Foundation ARC","award":["M2R20160604289"],"award-info":[{"award-number":["M2R20160604289"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.cancergen.2017.11.010","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T19:08:32Z","timestamp":1513105712000},"page":"31-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["ALK-TPM3 rearrangement in adult renal cell carcinoma: Report of a new case showing loss of chromosome 3 and literature review"],"prefix":"10.1016","volume":"221","author":[{"given":"Yohan","family":"Bodokh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Ambrosetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Kubiniek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branwel","family":"Tibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Durand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Amiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgane","family":"Pertuit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Barlier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Pedeutour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2017.11.010_bib0010","series-title":"WHO Classification of Tumours of the Urinary System and Male Genital Organs. WHO\/IARC Classification of Tumours","first-page":"9","article-title":"Tumours of the kidney","author":"Moch","year":"2016"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/j.semdp.2015.02.003","article-title":"MiT family translocation renal cell carcinoma","volume":"32","author":"Argani","year":"2015","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0020","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/modpathol.2010.213","article-title":"Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum","volume":"24","author":"Debelenko","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/gcc.20839","article-title":"ALK Rearrangement in sickle cell trait-associated renal medullary carcinoma","volume":"50","author":"Marino-Enriquez","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0030","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/PAS.0000000000000179","article-title":"VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy","volume":"38","author":"Smith","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0035","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/modpathol.2012.107","article-title":"ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients","volume":"25","author":"Sukov","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0040","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1002\/cncr.27391","article-title":"Identification of anaplastic lymphoma kinase fusions in renal cancer","volume":"118","author":"Sugawara","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0045","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.prp.2016.07.004","article-title":"TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: report of a case with a TPM3-ALK translocation","volume":"212","author":"Thorner","year":"2016","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0050","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/gcc.22346","article-title":"ALK-rearranged renal cell carcinomas in children","volume":"55","author":"Cajaiba","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0055","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/PAS.0000000000000610","article-title":"Two cases of renal cell carcinoma harboring a novel STRN-ALK fusion gene","volume":"40","author":"Kusano","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00428-013-1520-3","article-title":"Increased ALK1 copy number and renal cell carcinoma\u2014a case report","volume":"464","author":"Ryan","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0065","first-page":"135","article-title":"Comprehensive molecular characterization of papillary renal-cell carcinoma","volume":"347","author":"Linehan","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0070","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.prp.2016.07.015","article-title":"ALK rearrangements-associated renal cell carcinoma (RCC) with unique pathological features in an adult","volume":"212","author":"Jeanneau","year":"2016","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0075","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4132\/KoreanJPathol.2013.47.5.452","article-title":"ALK-positive renal cell carcinoma in a large series of consecutively resected Korean renal cell carcinoma patients","volume":"47","author":"Lee","year":"2013","journal-title":"Korean J Pathol"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0080","doi-asserted-by":"crossref","DOI":"10.1111\/his.13185","article-title":"Genetic analysis and clinicopathological features of ALK-rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature review","author":"Yu","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0085","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/gcc.22382","article-title":"Expanding the spectrum of ALK-rearranged renal cell carcinomas in children: identification of a novel HOOK1-ALK fusion transcript","volume":"55","author":"Cajaiba","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0090","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1148\/radiology.158.1.3510019","article-title":"The current radiological approach to renal cysts","volume":"158","author":"Bosniak","year":"1986","journal-title":"Radiology"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0095","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature10539","article-title":"A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma","volume":"480","author":"Bertolotto","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0100","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/PAS.0b013e318299f0fb","article-title":"The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters","volume":"37","author":"Delahunt","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0105","series-title":"An International System for Human Cytogenomic Nomenclature (2016)","author":"McGowan-Jordan","year":"2016"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2291","article-title":"The anaplastic lymphoma kinase in the pathogenesis of cancer","volume":"8","author":"Chiarle","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/mcs.a001115","article-title":"ALK: a tyrosine kinase target for cancer therapy","volume":"3","author":"Holla","year":"2017","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0120","first-page":"29","article-title":"Molecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomas","volume":"28","author":"Rao","year":"2016","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0125","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma","volume":"263","author":"Morris","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000133905","article-title":"Assignment of the human-tropomyosin gene TPM3 to 1q22-23 by fluorescence in situ hybridisation","volume":"68","author":"Wilton","year":"1995","journal-title":"Cytogenet Cell Genet"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0135","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.bbrc.2015.01.014","article-title":"Oncogenic TPM3-ALK activation requires dimerization through the coiled-coil structure of TPM3","volume":"13","author":"Amano","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0140","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/modpathol.3880352","article-title":"ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor","volume":"14","author":"Coffin","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0145","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/00000478-200106000-00007","article-title":"Anaplastic lymphoma kinase expression in inflammatory pseudotumors","volume":"25","author":"Chan","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0150","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ejca.2006.12.005","article-title":"TPM3-ALK expression induces changes in cytoskeleton organisation and confers higher metastatic capacities than other ALK fusion proteins","volume":"43","author":"Armstrong","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0155","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/gcc.22248","article-title":"Dismantling papillary renal cell carcinoma classification: the heterogeneity of genetic profiles suggests several independent diseases","volume":"54","author":"Marsaud","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.juro.2010.09.013","article-title":"Pathological, immunohistochemical and cytogenetic features of papillary renal cell carcinoma with clear cell features","volume":"185","author":"Klatte","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0165","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1158\/1078-0432.CCR-12-3825","article-title":"Genomic heterogeneity of translocation renal cell carcinoma","volume":"19","author":"Malouf","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0170","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/modpathol.2011.169","article-title":"Molecular heterogeneity of TFE3 activation in renal cell carcinoma","volume":"25","author":"Macher-Goeppinger","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0175","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/PAS.0000000000000835","article-title":"RBM10-TFE3 renal cell carcinoma: a potential diagnostic pitfall due to cryptic intrachromosomal Xp11.2 inversion resulting in false-negative TFE3 FISH","volume":"41","author":"Argani","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0180","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/PAS.0000000000000631","article-title":"TFE3-Fusion variant analysis defines specific clinicopathologic associations among Xp11 translocation cancers","volume":"40","author":"Argani","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0185","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/00000478-200306000-00005","article-title":"Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay","volume":"27","author":"Argani","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergen.2017.11.010_bib0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2217\/fon.15.293","article-title":"An update of ALK inhibitors in human clinical trials","volume":"12","author":"Chan","year":"2016","journal-title":"Future Oncol"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776217302600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776217302600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:41:44Z","timestamp":1761896504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776217302600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":37,"alternative-id":["S2210776217302600"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2017.11.010","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ALK-TPM3 rearrangement in adult renal cell carcinoma: Report of a new case showing loss of chromosome 3 and literature review","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2017.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}